Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Ocrelizumab (Ocrevus)

Each ml of solution contains 30 mg of Ocrelizumab
Ocrevus is a prescription medicine used to treat adults with relapsing or primary progressive forms of multiple sclerosis.

  • Presentation: Injection
  • Strength:  300mg/10ml  
  • Pack Size: 1 Vial
  • Pack Insert: Yes
  • Manufacturing License: 1048